Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy
Clinical Pharmacokinetics · 2024-03 · 63 (3) · 279-291
DOI: 10.1007/s40262-024-01358-3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 09.03.2024. Verfasst von Yi Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. Hauptthemen laut MEDLINE: Rivaroxaban, Polymorphism, Genetic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
- Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
- Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, 100191, China.
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
- Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. zhaorongsheng@bjmu.edu.cn.
- Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China. zhaorongsheng@bjmu.edu.cn.
ORCID-Profile: Zhanmiao Yi
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
Zitieren
APA
Ma, Y., Song, Z., Li, X., Jiang, D., Zhao, R., & Yi, Z. (2024). Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical Pharmacokinetics, 63(3), 279-291. https://doi.org/10.1007/s40262-024-01358-3
Vancouver
Ma Y, Song Z, Li X, Jiang D, Zhao R, Yi Z. Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical Pharmacokinetics. 2024;63(3):279-291. doi:10.1007/s40262-024-01358-3
BibTeX
@article{Ma2024,
author = {Ma, Yi and Song, Zaiwei and Li, Xinya and Jiang, Dan and Zhao, Rongsheng and Yi, Zhanmiao},
title = {Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy},
journal = {Clinical Pharmacokinetics},
year = {2024},
volume = {63},
number = {3},
pages = {279--291},
doi = {10.1007/s40262-024-01358-3}
}
EUVIMED